Maruho has contributed to people's health and better living for over 100 years since its founding in 1915.
Currently, as a pharmaceutical company specializing in dermatology,
we are developing business activities aimed at improving the QOL (Quality of Life) of patients.
In 2011, we launched our Long-Term Vision with the theme "Excellence in Dermatology", and we have strived to make further contributions to patients suffering from skin diseases. With the following four key phrases: "Dermatological Network," "Innovative Concepts," "Universal Medications with Excellent Value," and "Global Business," this new vision is designed to integrate dermatology-related knowledge and expertise from around the world, and to innovate along each step of the dermatological care cycle (prevention, diagnosis, treatment, and aftercare).
As we approach an age where life expectancy is said to be nearing 100 years, the health needs of patients are changing and diversifying on a daily basis. In order to meet the needs of patients who have been overlooked, or have given up treatment, we will come up with new ideas, create innovative products, and promptly deliver them to patients. We aim to realize a society where everyone can live with a smile.
- Representative Director,
President & CEOAtsushi Sugita
- Born in 1974, in Osaka Prefecture, Japan.
After graduating from Kyoto University in 1997, he went on to obtain an MBA from the Kellogg School of Management at Northwestern University in 2005. After working at foreign-affiliated pharmaceutical companies, etc., Sugita joined Maruho in 2012.
In 2013 he was appointed Associate General Manager, Global Business Development Dept. In October 2014 he was appointed Corporate Officer, North American Region, then in December the same year he was elected to the Maruho Board of Directors.
After becoming Senior Corporate Officer in charge of Global Strategy and Business Development, Finance and Accounting, and Human Resources, in 2021 he was appointed Executive Vice President in January of 2020. In December the same year, he was appointed President & CEO.